l9n/ Oregon

2021 Regular Session

House Bill 3267

Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria.

Did not become law. It stopped in the House of Representatives's Health Care Committee on June 26, 2021. The 2021 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or are expected to create affordability challenges for health systems and patients in Oregon or health inequities for communities of color. Requires board to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board. Establishes Prescription Drug Affordability Stakeholder Council to assist board in carrying out its duties.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

1 co-sponsor

Anna Williams

Its course

February 23 to June 26, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action3 actions on 3 days

In the House of RepresentativesFeb 23 to Jun 26 · stopped123 days

Waiting for a committeeFeb 23 to Feb 263 days

Health CareFeb 26 to Jun 26 · stopped120 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Feb 23 – Jun 26

  1. Introduced
  2. Sent to Health Care
  3. Died when the session ended
All 3 actions, as published